A PHASE I-II STUDY OF BIALKYLATOR CHEMOTHERAPY, HIGH-DOSE THIOTEPA, AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS BONE-MARROW REINFUSION IN PATIENTS WITH ADVANCED CANCER

被引：64
|
作者：
WILLIAMS, SF
BITRAN, JD
KAMINER, L
WESTBROOK, C
JACOBS, R
ASHENHURST, J
ROBIN, E
PURL, S
BESCHORNER, J
SCHROEDER, C
GOLOMB, HM
机构：
[1] UNIV CHICAGO,DEPT MED,JOINT SECT HEMATOL ONCOL,AUTOLOGOUS BONE MARROW TRANSPLANT PROGRAM,CHICAGO,IL 60637
[2] UNIV CHICAGO,MICHAEL REESE HOSP & MED CTR,CHICAGO,IL 60616
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1987年 / 5卷 / 02期
关键词：
D O I：
10.1200/JCO.1987.5.2.260
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：260 / 265
页数：6
相关论文
共 50 条
  • [31] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MYELOMA
    MCELWAIN, TJ
    SELBY, PJ
    GORE, ME
    VINER, C
    MELDRUM, M
    MILLAR, BC
    MALPAS, JS
    EUROPEAN JOURNAL OF HAEMATOLOGY, SUPPL NO 51, VOL 43, 1989: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON MULTIPLE MYELOMA - BIOLOGY, PATHOPHYSIOLOGY, PROGNOSIS AND TREATMENT, 1989, : 152 - 156
  • [32] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MYELOMA
    MCELWAIN, TJ
    SELBY, PJ
    GORE, ME
    VINER, C
    MELDRUM, M
    MILLAR, BC
    MALPAS, JS
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1989, 43 : 152 - 156
  • [33] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH REFRACTORY OVARIAN-CANCER
    MULDER, POM
    WILLEMSE, PHB
    AALDERS, JG
    DEVRIES, EGE
    SLEIJFER, DT
    SIBINGA, CTS
    MULDER, NH
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (04): : 645 - 649
  • [34] HEMATOLOGICAL EFFECTS OF HIGH-DOSE CYCLOPHOSPHAMIDE AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    HARPER, PG
    LINCH, DC
    GOLDSTONE, AH
    RICHARDS, JDM
    SOUHAMI, RL
    BRITISH JOURNAL OF HAEMATOLOGY, 1981, 49 (01) : 138 - 139
  • [35] HIGH-DOSE THIOTEPA AND MITOXANTRONE WITH AUTOLOGOUS STEM-CELL REINFUSION FOR REFRACTORY MALIGNANCIES - A PHASE-I-II STUDY
    FIELDS, KK
    ELFENBEIN, GJ
    HIEMENZ, JW
    ZORSKY, PE
    PACH, LD
    CLINICAL RESEARCH, 1992, 40 (02): : A421 - A421
  • [36] PREDICTION OF THE OPTIMAL TIMING OF BONE-MARROW REINFUSION AFTER HIGH-DOSE CHEMOTHERAPY
    EDER, JP
    BAST, RC
    PETERS, WP
    HENNER, D
    SANCHEZ, E
    SCHRYBER, S
    FREI, E
    SCHNIPPER, LE
    CANCER RESEARCH, 1986, 46 (09) : 4496 - 4499
  • [37] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADVANCED HODGKINS-DISEASE
    MORGAN, MJ
    DODDS, AJ
    WOLF, M
    JANUSZEWICZ, H
    MA, D
    DOWNS, K
    COOPER, I
    MEDICAL JOURNAL OF AUSTRALIA, 1992, 157 (08) : 527 - 530
  • [38] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW SUPPORT IN ADVANCED MALIGNANT-MELANOMA
    KOEPPLER, H
    PFLUEGER, KH
    SEITZ, R
    HAVEMANN, K
    ONKOLOGIE, 1989, 12 (06): : 277 - 279
  • [39] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW SUPPORT IN ADVANCED MALIGNANT-MELANOMA
    KOPPLER, H
    PFLUGER, KH
    HAVEMANN, K
    BLUT, 1988, 57 (04): : 208 - 208
  • [40] HIGH-DOSE BUSULFAN AND THIOTEPA WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CHILDHOOD MALIGNANT BRAIN-TUMORS - A PHASE-II STUDY
    KALIFA, C
    HARTMANN, O
    DEMEOCQ, F
    VASSAL, G
    COUANET, D
    TERRIERLACOMBE, MJ
    VALTEAU, D
    BRUGIERES, L
    LEMERLE, J
    BONE MARROW TRANSPLANTATION, 1992, 9 (04) : 227 - 233
12345